Celebrating 20 Years in Business
Thank you for being part of our development since September 2001. With your ongoing support we look forward to many exciting developments ahead.Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
SCIGEN LIMITED (SIE)
ASX, Legal & CGT Status
Former (or subsequent) names
Shareholder links
REGISTRY:
Computershare, Level 5, 115 Grenfell Street, Adelaide SA 5000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 8 9473 2408 or 1300 534 987
RegistryWebsite RegistryEmail
Company details
Tel: 02-9485-1800 Fax: 02-9485-1888
Date first listed: 15/11/2002
Company Secretary:
Sector: Pharmaceuticals & Biotechnology
Industry Group: XHJ
Activities: Biopharmaceutical company that manufactures and delivers healthcare products globally - its focus is in the areas of endocrinology and immunology and its product portfolio includes vaccines and therapeutics
News & Events
delisted from the close of trading on Tuesday, 28 August 2018 pursuant to Listing rule 17.14. | 28/08/2018 |
we understand SAC Capital Private Limited was successful with an offer of US$0.0507 cash per Scigen share | 28/08/2018 |
the suspension of trading in the securities of SciGen Limited (the "Company") will be lifted on the commencement of trading on Friday, 3 April 2009, following receipt of the Company's Full Year Accounts for the period ended 31 December 2008, in accordance with listing rule 17.8 | 02/04/2009 |
shares suspended from quotation following failure to lodge full year accounts | 01/04/2009 |
with regard to the demerger in December 2002, Sonic shareholders received one SciGen share in the form of a CUFS for every Sonic share held - Sonic advised the Australian Taxation Office that SciGen represented 0.66% of the market value of the group as a whole just after the demerger - according to the Australian Tax Office shareholders who received SciGen shares should use this percentage to apportion the sum of the cost bases of their post-CGT Sonic shares between these shares and the post-CGT SciGen shares | 31/12/2002 |
ASX Announcements (courtesy of ASX)
ASX, Legal & CGT Status
Your comments
Company Updates
Post your comments here
Directors' on-market share transactions (last 5)
Directors & Executives (current)
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Slawomir Ziegert | Executive Chairman, CEO | 01/12/2009 |
| Marcin Dukaczewski | Non Exec Director | 26/12/2008 |
| Mateusz Kosecki | Non Exec Director | 01/12/2009 |
| Yvonne Lim | Executive Director | 08/09/2017 |
| Zou Jun | Director | 07/08/2018 |
| Yanzhi Shi | Director | 08/08/2018 |
| Kang Yun | Director | 07/08/2018 |
Date of first appointment, title may have changed.
Directors & Executives (former)
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Marek Dziki | Non Exec Chairman, CEO | 06/06/2016 | 31/08/2018 |
| Adam Polonek | Executive Director, CFO | 26/06/2008 | 31/08/2018 |
| Ju bo Liu | Non Exec Director | 10/02/2017 | 07/08/2018 |
| Vaidyanathan Viswanath | Non Exec Director | 10/02/2017 | 07/08/2018 |
| Kenneth Gross | Non Exec Director | 03/07/2000 | 07/08/2018 |
| Ashley Morris | Executive Director, CEO | 09/02/2017 | 08/09/2017 |
| Jenny Low | Executive Director, Administrator | 02/12/2009 | 30/06/2017 |
| James Kim | Executive Director | 18/04/2016 | 09/02/2017 |
| Adam Wilczega | Non Exec Director | 11/04/2005 | 01/04/2016 |
| Joanna Szymanska-Bulska | Non Exec Director | 26/06/2008 | 06/06/2014 |
| Amol Shah | Non Exec Director | 01/12/2009 | 25/04/2014 |
| Adam Aleksandrowicz | Executive Director, CFO | 03/03/2011 | 12/01/2012 |
Date of first appointment, title may have changed.